New York Eye and Ear Infirmary
Adjust: Text Size Make Font Smaller Make Font Larger Print this Page: Normal Print Friendly Large Print Friendly Accessibility Info

Anterior segment imaging using ultrasound biomicroscopy (UBM) and slit lamp optic coherence tomography (SL-OCT) in patients using alpha-adrenergic blockers

Principal Investigator 

Robert Ritch, M.D.

Objective

To detect differences in the iris thickness in patients on systemic alpha adrenergic blockers using UBM and SL-OCT

Eligibility

Patients on Flomax and that have used it in the past (for at least 6 months). Exclusion on Patients with any disease that could change iris morphology (uveitis, PDS, XFS, trauma...) or previous intraocular surgery.

Enrollment Goal

50 patients/ 50 controls (OPEN)

Contact Information

Carlos Gustavo Vasconcelos DeMoraes, MD
212-477-7540 Ext. 336
gustavonyee@gmail.com

Tiago Prata, MD
212-477-7540 Ext. 339
throb@uol.com.br

 

Home > Current Research > Clinical Trials in Ophthalmology > Anterior segment imaging using ultrasound biomicroscopy (UBM) and slit lamp optic coherence tomography (SL-OCT) in patients using alpha-adrenergic blockers.